Linked Data API

Show Search Form

Search Results

100723
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Motor Neurone Disease: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to prevent or treat symptoms of motore neurone disease in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211734 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100728
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Motor Neurone Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much from the public purse has been spent on research into motor neurone disease in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211730 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100730
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Osteoporosis: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to treat symptoms of osteoporosis in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211735 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100885
registered interest false more like this
date less than 2014-10-24more like thismore than 2014-10-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much the Government has spent on the development of new drugs to treat the symptoms of asthma in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211885 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:29.113Zmore like thismore than 2014-10-29T17:12:29.113Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100887
registered interest false more like this
date less than 2014-10-24more like thismore than 2014-10-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much public funding was allocated to research into asthma in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211918 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
101492
registered interest false more like this
date less than 2014-10-28more like thismore than 2014-10-28
answering body
Ministry of Justice more like this
answering dept id 54 more like this
answering dept short name Justice more like this
answering dept sort name Justice more like this
hansard heading Prisons: Locks and Keys more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Justice, how many incidents of lost keys have required the relocking of prisons since May 2010; and at what cost. more like this
tabling member constituency Tooting more like this
tabling member printed
Sadiq Khan more like this
uin 212348 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-11-03more like thismore than 2014-11-03
answer text <p>Security is paramount within prisons and it is important that the risk of any potential key compromise is addressed as quickly as possible in order to protect the public. When a key/lock incident is reported an immediate investigation is undertaken to assess the risk and unless it is clear that security has not been compromised, then locking mechanisms and keys will be replaced and/or other necessary remedial action will be taken.</p><p> </p><p>A range of procedural and physical measures are used to assist in the secure management of keys in prisons. These increasingly include electronic and biometric systems.</p><p> </p><p>The information requested is provided below.</p><p> </p><p>Table 1 - costs of partial/full relocking of prisons due to loss of keys from May 2010 - 29 October 2014:</p><p> </p><p>14/05/2010 Swaleside £95,430</p><p>21/06/2010 Glen Parva £208,329</p><p>04/11/2010 Warren Hill £101,301</p><p>20/12/2010 Ashwell £15,576</p><p>24/10/2011 Birmingham £499,000 <ins class="ministerial">(Paid for by G4S)</ins></p><p>09/01/2012 Maidstone £5,847</p><p>28/02/2014 Lindholme £40,286</p><p>08/05/2014 Haverigg £32,882</p><p>21/07/2014 Highpoint £14, 933</p><p> </p><p>Table 2 – number of reported incidents of lost keys from April 2010 – 31 March 2014:</p><p> </p><p>2010/11 - 62</p><p>2011/12 - 67</p><p>2012/13 – 73</p><p>2013/14 – 35 (* see note below)</p><p> </p><p>* Note: a change in the reporting requirements for key/lock incidents from April 2013 has resulted in a lower “lost keys” figure for 2013/14 in comparison to the three previous years. In addition to keys “lost”, the figures for the three previous years include keys inadvertently taken out of prisons and subsequently returned, but the figure for 2013/14 includes only keys lost, not those inadvertently taken out and returned.</p><p> </p><p><em>The figures quoted have been drawn from live administrative databases and may subsequently be amended. Due care is taken during processing and analysis, but the detail is subject to inaccuracies inherent in any large scale recording system.</em></p>
answering member constituency South West Bedfordshire more like this
answering member printed Andrew Selous more like this
question first answered
less than 2014-11-03T11:21:01.633Zmore like thismore than 2014-11-03T11:21:01.633Z
question first ministerially corrected
less than 2014-11-03T17:23:08.2551012Zmore like thismore than 2014-11-03T17:23:08.2551012Z
answering member
1453
label Biography information for Andrew Selous more like this
previous answer version
25520
answering member constituency South West Bedfordshire more like this
answering member printed Andrew Selous more like this
answering member
1453
label Biography information for Andrew Selous more like this
tabling member
1577
label Biography information for Sadiq Khan more like this
101493
registered interest false more like this
date less than 2014-10-28more like thismore than 2014-10-28
answering body
Ministry of Justice more like this
answering dept id 54 more like this
answering dept short name Justice more like this
answering dept sort name Justice more like this
hansard heading Prisons: Locks and Keys more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Justice, how many incidents of lost keys there have been in prisons in each year since May 2010. more like this
tabling member constituency Tooting more like this
tabling member printed
Sadiq Khan more like this
uin 212349 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-11-03more like thismore than 2014-11-03
answer text <p>Security is paramount within prisons and it is important that the risk of any potential key compromise is addressed as quickly as possible in order to protect the public. When a key/lock incident is reported an immediate investigation is undertaken to assess the risk and unless it is clear that security has not been compromised, then locking mechanisms and keys will be replaced and/or other necessary remedial action will be taken.</p><p> </p><p>A range of procedural and physical measures are used to assist in the secure management of keys in prisons. These increasingly include electronic and biometric systems.</p><p> </p><p>The information requested is provided below.</p><p> </p><p>Table 1 - costs of partial/full relocking of prisons due to loss of keys from May 2010 - 29 October 2014:</p><p> </p><p>14/05/2010 Swaleside £95,430</p><p>21/06/2010 Glen Parva £208,329</p><p>04/11/2010 Warren Hill £101,301</p><p>20/12/2010 Ashwell £15,576</p><p>24/10/2011 Birmingham £499,000 <ins class="ministerial">(Paid for by G4S)</ins></p><p>09/01/2012 Maidstone £5,847</p><p>28/02/2014 Lindholme £40,286</p><p>08/05/2014 Haverigg £32,882</p><p>21/07/2014 Highpoint £14, 933</p><p> </p><p>Table 2 – number of reported incidents of lost keys from April 2010 – 31 March 2014:</p><p> </p><p>2010/11 - 62</p><p>2011/12 - 67</p><p>2012/13 – 73</p><p>2013/14 – 35 (* see note below)</p><p> </p><p>* Note: a change in the reporting requirements for key/lock incidents from April 2013 has resulted in a lower “lost keys” figure for 2013/14 in comparison to the three previous years. In addition to keys “lost”, the figures for the three previous years include keys inadvertently taken out of prisons and subsequently returned, but the figure for 2013/14 includes only keys lost, not those inadvertently taken out and returned.</p><p> </p><p><em>The figures quoted have been drawn from live administrative databases and may subsequently be amended. Due care is taken during processing and analysis, but the detail is subject to inaccuracies inherent in any large scale recording system.</em></p>
answering member constituency South West Bedfordshire more like this
answering member printed Andrew Selous more like this
question first answered
less than 2014-11-03T11:21:01.78Zmore like thismore than 2014-11-03T11:21:01.78Z
question first ministerially corrected
less than 2014-11-03T17:29:21.2681994Zmore like thismore than 2014-11-03T17:29:21.2681994Z
answering member
1453
label Biography information for Andrew Selous more like this
previous answer version
25521
answering member constituency South West Bedfordshire more like this
answering member printed Andrew Selous more like this
answering member
1453
label Biography information for Andrew Selous more like this
tabling member
1577
label Biography information for Sadiq Khan more like this
101535
registered interest false more like this
date less than 2014-10-29more like thismore than 2014-10-29
answering body
Department for Communities and Local Government more like this
answering dept id 7 more like this
answering dept short name Communities and Local Government more like this
answering dept sort name Communities and Local Government more like this
hansard heading Lighting more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Communities and Local Government, what guidance his Department has issued to local authorities on the level of street lighting they should have in place. more like this
tabling member constituency Bury St Edmunds more like this
tabling member printed
Mr David Ruffley more like this
uin 212384 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-11-06more like thismore than 2014-11-06
answer text <p><ins class="ministerial">Street lighting plays an important role in road safety, as well as ensuring the personal safety of pedestrians. I refer my Hon Friend to the answer of 13 May 2014, Official Report, columns 535-36W, which provides a comprehensive answer on how there is no prescriptive Whitehall guidance, and places in context the policy of the last Administration which actively encouraged cuts to street lighting.</ins></p><p> </p><p> </p><p><del class="ministerial">Street lighting plays an important role in road safety, as well as ensuring the personal safety of pedestrians. There may be some roads where lights could be dimmed in the very early hours, saving taxpayers’ money. However, this should be a local decision by elected local councillors, reflecting local circumstances-specially in relation to any concerns about crime. Equally, not every neighbourhood wants street lighting, as some communities, especially in rural areas, value dark skies.</del></p><p><del class="ministerial">We believe that councils should listen to the views of their local residents, and then adopt appropriate local policies based on the neighbourhood, the precise location and the usage of the road/street. I previously noted that “Manual for Streets” contains some useful guidance on getting the balance right when providing street lighting, taking into account the different issues around safety, crime prevention, street clutter and light pollution. Ultimately, there is no prescriptive Whitehall guidance, and any assessment will depend on local circumstances and local views.</del></p><p><del class="ministerial">Notwithstanding, I would observe that Her Majesty’s Opposition seem to have a short memory about their actions on cutting street lighting when they were in office:</del></p><p><del class="ministerial"><em>Department for Environment, Food and Rural Affairs</em><em>:</em></del></p><p><del class="ministerial">The right hon. Member for Leeds Central (Hilary Benn) (now Shadow Secretary of State for Communities and Local Government) when Secretary of State for Environment, Food and Rural Affairs, his Department and its quangos lectured local councils to switch off or reduce street lighting to minimise carbon emissions. For example, in 2007, he personally launched the Carbon Trust Standard, which was tied to an extensive programme to reduce street lighting as part of the Local Authority Carbon Management Programme. As DEFRA Ministers told the House:</del></p><p><del class="ministerial">“All authorities should be seeking to reduce energy usage both to cut costs and to help combat climate change. As street lighting accounts for a significant proportion of the energy used by authorities, it should be readily identified as an area that should be examined for potential efficiency savings”</del></p><p><del class="ministerial">(6 November 2006, <em>Official Report</em>, column 709W).</del></p><p><del class="ministerial"><em>Department for Transport</em><em>:</em></del></p><p><del class="ministerial">The Minister of State for Transport, the noble Lord Adonis (now a Shadow Treasury Minister) when asked about reducing the hours of operation of street lighting, noted that</del></p><p><del class="ministerial">“the Government also support the Carbon Trust’s local authority carbon management programme, which provides councils with support and guidance to help them realise carbon emissions savings from street lighting”</del></p><p><del class="ministerial">(17 December 2008, <em>Official Report</em>, <em>House of Lords</em>, column WA52). Transport Ministers also endorsed the Highways Agency’s</del></p><p><del class="ministerial">‘Efficiency Strategy for Road Lighting’ which led to switching off motorway lighting at night (21 April 2008,</del></p><p><br /><del class="ministerial"><em>Official Report, </em>column 1444W; Highways Agency</del></p><p><del class="ministerial">“Efficiency Strategy for Road Lighting Midnight Switch Off for Motorway Lighting”, 2009).</del></p><p><del class="ministerial"><em>Department for Communities and Local Government</em><em>:</em></del></p><p><del class="ministerial">The right hon. Member for Normanton, Pontefract and Castleford (Yvette Cooper) (now Shadow Home Secretary), when as Minister in the precursor Department to DCLG, noted there was nuanced debate on the extent of street lighting:</del></p><p><del class="ministerial">“We all recognise the fact that there is a series of tensions around light pollution. People in the cities will never have the same view of the night sky as one can get in the middle of Dartmoor... There can be tensions too at neighbourhood level between the security-obsessed householder who has glaring white security lights stuck to every corner of the house, which flicker on every time a little bird flies past or the cat runs across the garden, and the neighbour who... has a telescope and cannot see across the garden, let alone into the skies”</del></p><p><del class="ministerial">(12 February 2004, <em>Official Report</em>, column 510WH).</del></p><p><del class="ministerial"><em>Department </em><em>of</em><em> Energy and Climate Change</em><em>:</em></del></p><p><del class="ministerial">In 2008, the right hon. Member for Leeds East (Hilary Benn) also personally launched the Carbon Reduction Commitment, which resulted in councils cutting carbon emissions from street lighting, including dimming or switching off lights. The Highway Agency’s “Energy Strategy for Roadside Equipment” (April 2010) explained that the approach of “dimming, trimming and partial night lighting” was a consequence of the requirements to meet the Carbon Reduction Commitment. As DECC Ministers said to the House:</del></p><p><del class="ministerial">“DECC is working to include street lighting in the Carbon Reduction Commitment. This will provide an incentive for local authorities to improve the energy efficiency of street lights. DECC is working closely with Communities and Local Government to develop the policy, in so far as it relates to local authorities”</del></p><p><del class="ministerial">(19 June 2009, <em>Official Report</em>, column 515W). Of course, the Secretary of State for Energy and Climate Change at that time was the right hon. Member for Doncaster North (Edward Miliband) now Leader of HM Opposition.</del></p><p><del class="ministerial">I hope this illuminates the historical fogginess of the Labour party’s current campaign on municipal street lighting. I would suggest the last person out of Labour HQ tonight should turn off the lights.</del></p><p> </p>
answering member constituency Keighley more like this
answering member printed Kris Hopkins more like this
question first answered
less than 2014-11-06T17:31:07.79Zmore like thismore than 2014-11-06T17:31:07.79Z
question first ministerially corrected
less than 2014-11-10T17:19:10.1286961Zmore like thismore than 2014-11-10T17:19:10.1286961Z
answering member
4043
label Biography information for Kris Hopkins more like this
previous answer version
26617
answering member constituency Keighley more like this
answering member printed Kris Hopkins more like this
answering member
4043
label Biography information for Kris Hopkins more like this
tabling member
133
label Biography information for Mr David Ruffley more like this
105978
registered interest false more like this
date less than 2014-11-03more like thismore than 2014-11-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Pay more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many Instant Rewards of what value were given to his Department's officials in (a) 2013 and (b) 2014 to date. more like this
tabling member constituency Barrow and Furness more like this
tabling member printed
John Woodcock more like this
uin 213068 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-11-10more like thismore than 2014-11-10
answer text <p><del class="ministerial">The Civil Service Commission publish details of appointments made by exception and approved by them in their annual reports and on their website. These reports are available in the Library.</del></p><p><br /><del class="ministerial">It would not be appropriate to publish details of the requests turned down by the Commission as the numbers involved are small, and the individuals might be personally identified, directly or in combination with other published information.</del></p><p> </p><p><ins class="ministerial">The Department does not operate an ‘Instant Rewards’ scheme. The Department does, however, operate an in-year bonus scheme, which has strict criteria, approval processes and budgetary control.</ins></p><p> </p> more like this
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
question first answered
less than 2014-11-10T16:58:06.487Zmore like thismore than 2014-11-10T16:58:06.487Z
question first ministerially corrected
less than 2014-11-10T17:38:55.2793146Zmore like thismore than 2014-11-10T17:38:55.2793146Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
previous answer version
27280
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
3917
label Biography information for Lord Walney more like this
155437
registered interest false more like this
date less than 2014-11-11more like thismore than 2014-11-11
answering body
Ministry of Defence more like this
answering dept id 11 more like this
answering dept short name Defence more like this
answering dept sort name Defence more like this
hansard heading Armed Forces: Young People more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Defence, with reference to his letter to the Defence Committee of 1 August 2014, whether the cost-benefit analysis of the recruitment of minors was based on (a) the final analysis or (b) the draft cost-benefit analysis; and if he will make a statement. more like this
tabling member constituency Bridgend more like this
tabling member printed
Mrs Madeleine Moon more like this
uin 214174 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-11-27more like thismore than 2014-11-27
answer text <p>The figures used in my right hon. Friend the Defence Secretary's letter of 1 August 2014 to the Defence Committee were taken from the final version of the cost-benefit analysis.</p><p>The report has been finalised and a copy is attached<ins class="ministerial">.</ins></p><p> </p> more like this
answering member constituency Broxtowe more like this
answering member printed Anna Soubry more like this
attachment
1
file name AFC CO's Supervisory Care Directive dated Sep 14.doc more like this
title Army Foundation College Supervisory Care Directive more like this
2
file name 20140514-Junior Entry_CostBenefitAnalysis_CITGvs 8_OS (3)[2].doc more like this
title Army Junior Entry Training Cost Benefit Analysis more like this
previous answer version
29898
answering member constituency Broxtowe more like this
answering member printed Anna Soubry more like this
answering member
3938
label Biography information for Anna Soubry more like this
30491
answering member constituency Broxtowe more like this
answering member printed Anna Soubry more like this
attachment
1
file name 20140514-Junior Entry_CostBenefitAnalysis_CITGvs 8_OS (3).doc more like this
title Army Junior Entry Training Cost Benefit Alaysis more like this
2
file name AFC CO's Supervisory Care Directive dated Sep 14.doc more like this
title Army Foundation College Supervisory Care Directive more like this
answering member
3938
label Biography information for Anna Soubry more like this
question first answered
less than 2014-11-27T16:12:57.807Zmore like thismore than 2014-11-27T16:12:57.807Z
question first ministerially corrected
less than 2015-01-22T11:08:57.93Zmore like thismore than 2015-01-22T11:08:57.93Z
answering member
3938
label Biography information for Anna Soubry more like this
tabling member
1490
label Biography information for Mrs Madeleine Moon more like this